327 related articles for article (PubMed ID: 10717614)
21. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
Le Péchoux C; Arriagada R; Le Chevalier T
Cancer; 1995 Aug; 76(3):530-1. PubMed ID: 8625139
[No Abstract] [Full Text] [Related]
22. Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non-Small Cell Lung Cancer.
Tang C; Lee MS; Gomez D; Levy LB; Zhuang Y; Lu C; Liao Z; Komaki R
Am J Clin Oncol; 2017 Dec; 40(6):625-630. PubMed ID: 26165417
[TBL] [Abstract][Full Text] [Related]
23. Carboplatin/etoposide/radiation plus escalating doses of paclitaxel in stage III non-small cell lung cancer: a preliminary report.
Bonomi P; Faber LP; Recine D; Lincoln S
Semin Oncol; 1995 Aug; 22(4 Suppl 9):42-7. PubMed ID: 7644927
[TBL] [Abstract][Full Text] [Related]
24. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
26. Escalating paclitaxel doses combined with carboplatin/etoposide and thoracic radiotherapy as preoperative or definitive treatment for stage III non-small cell lung cancer.
Bonomi P; Siddiqui S; Lincoln S; Sharma M; Recine D; Warren W; Faber LP
Semin Oncol; 1996 Dec; 23(6 Suppl 16):102-7. PubMed ID: 9007134
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
Davies AM; Chansky K; Lau DH; Leigh BR; Gaspar LE; Weiss GR; Wozniak AJ; Crowley JJ; Gandara DR;
J Clin Oncol; 2006 Nov; 24(33):5242-6. PubMed ID: 17114656
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update.
Kris MG; Gaspar LE; Chaft JE; Kennedy EB; Azzoli CG; Ellis PM; Lin SH; Pass HI; Seth R; Shepherd FA; Spigel DR; Strawn JR; Ung YC; Weyant M
J Clin Oncol; 2017 Sep; 35(25):2960-2974. PubMed ID: 28437162
[TBL] [Abstract][Full Text] [Related]
29. ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy.
Hwang IG; Ahn MJ; Park BB; Ahn YC; Han J; Lee S; Kim J; Shim YM; Ahn JS; Park K
Cancer; 2008 Sep; 113(6):1379-86. PubMed ID: 18623378
[TBL] [Abstract][Full Text] [Related]
30. Docetaxel-based combined-modality chemoradiotherapy for locally advanced non-small cell lung cancer.
Scagliotti GV; Turrisi AT
Oncologist; 2003; 8(4):361-74. PubMed ID: 12897333
[TBL] [Abstract][Full Text] [Related]
31. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
Choong NW; Vokes EE; Haraf DJ; Tothy PK; Ferguson MK; Kasza K; Rudin CM; Hoffman PC; Krauss SA; Szeto L; Mauer AM
J Thorac Oncol; 2008 Jan; 3(1):59-67. PubMed ID: 18166842
[TBL] [Abstract][Full Text] [Related]
32. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
33. Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer.
Daly BD; Fernando HC; Ketchedjian A; Dipetrillo TA; Kachnic LA; Morelli DM; Shemin RJ
Ann Thorac Surg; 2006 Jul; 82(1):227-31. PubMed ID: 16798219
[TBL] [Abstract][Full Text] [Related]
34. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
Chang AY; Kim K; Boucher H; Bonomi P; Stewart JA; Karp DD; Blum RH
Cancer; 1998 Jan; 82(2):292-300. PubMed ID: 9445185
[TBL] [Abstract][Full Text] [Related]
35. Chemoradiotherapy in non-small cell lung cancer: paclitaxel/carboplatin/radiotherapy in regionally advanced disease.
Belani CP; Aisner J; Bahri S; Jett J; Day R; Capazolli MJ; Hiponia D; Engstrom C
Semin Oncol; 1996 Dec; 23(6 Suppl 16):113-6. PubMed ID: 9007136
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques).
Dautzenberg B; Chastang C; Arriagada R; Le Chevalier T; Belpomme D; Hurdebourcq M; Lebeau B; Fabre C; Charvolin P; Guérin RA
Cancer; 1995 Sep; 76(5):779-86. PubMed ID: 8625180
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small cell lung cancer.
Choy H; Akerley W; Safran H; Graziano S; Chung C
Semin Oncol; 1996 Dec; 23(6 Suppl 16):117-9. PubMed ID: 9007137
[TBL] [Abstract][Full Text] [Related]
38. [Estimation of preoperative induction chemoradiotherapy effectiveness for non small-cell lung cancer].
Sanada H; Hayashi A; Tomimitsu S; Ikeda K; Nakanishi K; Hiyama J; Hidaka D; Sawamoto R; Miyagawa Y; Misumi Y; Fujii A; Nakatsubo S; Tsuru M; Omagari J; Koshizuka H
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2012-5. PubMed ID: 20037308
[TBL] [Abstract][Full Text] [Related]
39. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.
Dillman RO; Herndon J; Seagren SL; Eaton WL; Green MR
J Natl Cancer Inst; 1996 Sep; 88(17):1210-5. PubMed ID: 8780630
[TBL] [Abstract][Full Text] [Related]
40. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
Bradley JD; Paulus R; Graham MV; Ettinger DS; Johnstone DW; Pilepich MV; Machtay M; Komaki R; Atkins J; Curran WJ;
J Clin Oncol; 2005 May; 23(15):3480-7. PubMed ID: 15908657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
